1. EVITA: PHASE I/II STUDY OF EVEROLIMUS PLUS ITACITINIB IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA. (12th June 2019) Authors: Svoboda, J.; Barta, S.; Nasta, S.; Landsburg, D.; Gerson, J.; Ruella, M.; Waite, T.; King, C.; Emanuel, S.A.; Ballard, H.; Schuster, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗